Role of adenovirus type 5 early region 3 in the pathogenesis of ocular disease and cell culture infection
- PMID: 7600812
- DOI: 10.1097/00003226-199505000-00009
Role of adenovirus type 5 early region 3 in the pathogenesis of ocular disease and cell culture infection
Abstract
Experimental animal virus replication models make it possible to study the role of viral gene products in adenovirus (Ad)-induced ocular disease. This study tested the hypothesis that the early region 3 (E3) of the human Ad genome plays an important role in the pathogenesis of Ad-induced ocular disease. Both Ad5 wt300, a genetically defined E3+ parent, and Ad5 dl327, a deletion mutant without E3 (E3-), replicated in ocular-derived cell cultures. Ad5 E3+ and Ad8 replicated more efficiently than did Ad5 E3- in cornea and conjunctival cell cultures. Lacrimal gland-derived cell cultures supported human Ad8 replication significantly more efficiently than did either Ad5 E3+ or Ad5 E3-. After intrastromal and topical inoculation of rabbits with either Ad wt300 or Ad dl327, a specific immune response was elicited that coincided with the appearance of subepithelial opacities that mimicked human disease both clinically and histologically. The clinical features (i.e., conjunctivitis, iritis, and corneal edema) were not significantly different for Ad5 E3(+)- and Ad5 E3(-)-induced ocular infection. Ad5 E3(+)- and Ad5 E3(-)-inoculated eyes shed virus for up to 7 and 5 days, respectively, and occasionally established persistent and/or latent infections in corneal, conjunctival, and, infrequently, lacrimal gland cells. Both Ad5 E3+ and Ad5 E3- spread from virus-inoculated animals to the cornea and conjunctiva of normal animals. Under current experimental conditions, expression of the E3 gene does not appear to affect the degree of virulence in ocular disease induced by Ad5 in the rabbit eye model. Deletion of the E3 gene from Ad5 does not make the model more like human disease.
Similar articles
-
Efficacy of topical immunoglobulins against experimental adenoviral ocular infection.Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4171-6. doi: 10.1167/iovs.07-0491. Invest Ophthalmol Vis Sci. 2007. PMID: 17724203 Free PMC article.
-
Studies of adenovirus-induced eye disease in the rabbit model.Invest Ophthalmol Vis Sci. 1995 Dec;36(13):2740-8. Invest Ophthalmol Vis Sci. 1995. PMID: 7499096
-
Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.Cornea. 2005 Jan;24(1):86-91. doi: 10.1097/01.ico.0000127481.23714.b6. Cornea. 2005. PMID: 15604872
-
The life and times of adenoviruses.Adv Virus Res. 1999;54:1-13. doi: 10.1016/s0065-3527(08)60363-2. Adv Virus Res. 1999. PMID: 10547672 Review.
-
Mystery eye: Human adenovirus and the enigma of epidemic keratoconjunctivitis.Prog Retin Eye Res. 2020 May;76:100826. doi: 10.1016/j.preteyeres.2019.100826. Epub 2019 Dec 28. Prog Retin Eye Res. 2020. PMID: 31891773 Free PMC article. Review.
Cited by
-
Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).Trans Am Ophthalmol Soc. 2006;104:346-65. Trans Am Ophthalmol Soc. 2006. PMID: 17471351 Free PMC article.
-
Genomic foundations of evolution and ocular pathogenesis in human adenovirus species D.FEBS Lett. 2019 Dec;593(24):3583-3608. doi: 10.1002/1873-3468.13693. Epub 2019 Dec 11. FEBS Lett. 2019. PMID: 31769017 Free PMC article. Review.
-
Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?Vaccine. 2011 Aug 11;29(35):5824-36. doi: 10.1016/j.vaccine.2011.06.083. Epub 2011 Jun 28. Vaccine. 2011. PMID: 21718746 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources